Vinorelbine plus low-dose cisplatinum with concomitant radiotherapy for the treatment of locally advanced or inoperable non-metastasized non-small-cell lung cancer (stage I-IIIB): a phase II study

被引：5

作者：

Winterhalder, R

Deschler-Marini, S

Landmann, C

Kann, R

Passweg, J

Herrmann, R

Pless, M

机构：

[1] Univ Basel Hosp, Dept Oncol, CH-4031 Basel, Switzerland

[2] Univ Basel Hosp, Dept Radiat Oncol, CH-4031 Basel, Switzerland

[3] Univ Basel Hosp, Dept Hematol, CH-4031 Basel, Switzerland

来源：

RADIOTHERAPY AND ONCOLOGY | 2004年 / 73卷 / 03期

关键词：

low-dose cisplatin and weekly vinorelbine; concomitant chemoradiation; stage IIIBNSCLC;

D O I：

10.1016/j.radonc.2004.06.009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In a phase II study. we assessed the toxicity and efficacy of daily low-dose cisplatin (6 mg/m(2)) and weekly vinorelbine (15 mg/m(2)) with concurrent thoracic irradiation (60 Gy) for locally advanced non-metastasized non-small-cell lung cancer. The overall response rate was 65%, complete response 12% and the median overall survival was 64 weeks. (C) 2004 Elsevier Ireland Ltd. All rights reserved.

引用

页码：321 / 324

页数：4

共 50 条

[1] Combined radiotherapy - Chemotherapy with vinorelbine in locally advanced, inoperable non small cell lung cancer (NSCLC) stage IIIB
Vomvas, D.
Pomoni, M.
Kardamakis, D.
RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S301 - S301
[2] Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer
Isokangas, OP
Knuuttila, A
Halme, M
Mäntylä, M
Lindström, I
Nikkanen, V
Viren, M
Joensuu, H
Mattson, K
ANNALS OF ONCOLOGY, 1999, 10 (09) : 1059 - 1063
[3] Phase I/II study of vinorelbine, mitomycin, and cisplatin for stage IIIB or IV non-small-cell lung cancer
Furuse, K
Kawahara, M
Nishiwaki, Y
Fukuoka, M
Takada, M
Miyashita, M
Ohashi, Y
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) : 3195 - 3200
[4] VINORELBINE PLUS CISPLATINUM FOR THE TREATMENT OF STAGE-IIIB AND STAGE-IV NON-SMALL-CELL LUNG-CARCINOMA
GEBBIA, V
CARUSO, M
VALENZA, R
TESTA, A
CANNATA, G
VERDERAME, F
CIPOLLA, C
CURTO, G
OLIVERI, D
CHIARENZA, M
LATTERI, MA
DIGESU, G
GEBBIA, N
ANTICANCER RESEARCH, 1994, 14 (3B) : 1247 - 1249
[5] Phase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancer
Ishida, Koko
Hirose, Takashi
Yokouchi, Junichi
Oki, Yasunari
Kusumoto, Sojiro
Sugiyama, Tomohide
Ishida, Hiroo
Shirai, Takao
Nakashima, Masanao
Yamaoka, Toshimitsu
Ohnishi, Tsukasa
Ohmori, Tohru
Kagami, Yoshikazu
MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (03) : 405 - 410
[6] Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: A phase I study
Frasci, G
Panza, N
Comella, P
Nicolella, GP
Natale, M
Pacilio, C
Gravina, A
Caputi, V
Botti, G
Comella, G
ANNALS OF ONCOLOGY, 1997, 8 (10) : 1045 - 1048
[7] Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer
Masters, GA
Hoffman, PC
Hsieh, AL
Drinkard, LC
Mick, R
Samuels, BL
Guaspari, A
Golomb, HM
Vokes, EE
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 884 - 892
[8] Continuous-infusion vinorelbine for the treatment of advanced non-small-cell lung cancer:: A phase I/II study
Carabante-Ocon, Francisco
Cobo-Dols, Manuel
Benavides-Orgaz, Manuel
Gil-Calle, Silvia
Ales-Diaz, Inmaculada
Breton-Garcia, Juan J.
Villar-Chamorro, Esther
Montesa-Pino, Alvaro
Alcalde-Garcia, Julia
Gutierrez-Calderon, Vanesa
CLINICAL LUNG CANCER, 2005, 7 (02) : 121 - 126
[9] Carboplatin and vinorelbine in the treatment of advanced non-small-cell lung cancer - A multicenter phase II study
Santomaggio, C
Tucci, E
Rinaldini, M
Algeri, R
Righi, R
Pepi, F
Ghezzi, P
Andrei, A
Bellezza, A
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (01): : 67 - 71
[10] Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer
Baldini, E
Tibaldi, C
Chella, A
Angeletti, CA
Silvano, G
Andrei, A
Algeri, R
Conte, PF
ANNALS OF ONCOLOGY, 1996, 7 (07) : 747 - 749

← 1 2 3 4 5 →